- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: carfilzomib, lenalidomide plus dexamethasone
Total 538 results
-
University of ArkansasWithdrawn
-
Dana-Farber Cancer InstituteBristol-Myers SquibbNo longer availableMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Hackensack Meridian HealthAmgenRecruitingMultiple MyelomaUnited States
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI); City of Hope Medical Center and other collaboratorsCompletedRecurrent Plasma Cell MyelomaUnited States
-
Washington University School of MedicineCompleted
-
Mayo ClinicCompletedMultiple Myeloma | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
Ocular Therapeutix, Inc.CompletedPost Ocular Surgical Inflammation and PainUnited States
-
Peter MacCallum Cancer Centre, AustraliaCelgene CorporationUnknown
-
Hamad Medical CorporationCompleted
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited Kingdom, United States, France, Netherlands, Denmark
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
TakedaTerminatedRelapsed and/or Refractory Multiple Myeloma
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaHong Kong, Korea, Republic of, Singapore
-
Gruppo Italiano Studio LinfomiUnknown
-
Hackensack Meridian HealthKaryopharm Therapeutics IncRecruitingMultiple MyelomaUnited States
-
National University Hospital, SingaporeNational University of SingaporeRecruiting
-
Vanderbilt-Ingram Cancer CenterCompleted
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States
-
CelgeneCompletedMultiple MyelomaUnited States, Canada, Germany, Spain, Denmark, Netherlands, Finland, Italy
-
Raija SilvennoinenTakeda; Celgene; Nordic Myeloma Study GroupActive, not recruitingMultiple MyelomaNorway, Sweden, Finland, Lithuania
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
Millennium Pharmaceuticals, Inc.Completed
-
Cantonal Hospital of St. GallenCelgene Corporation; Amgen; Mundipharma Medical Company; Mundipharma Research GmbH...Completed
-
Ajai ChariNovartis PharmaceuticalsCompletedMultiple MyelomaUnited States
-
Leap Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
University of Colorado, DenverTerminatedRefractory Plasma Cell MyelomaUnited States
-
Bristol-Myers SquibbAbbVieActive, not recruitingMultiple MyelomaUnited States, Canada, Australia, Poland, Italy, Belgium, Spain, Japan, Greece, Hungary, Romania, Turkey, United Kingdom
-
Epizyme, Inc.WithdrawnRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)WithdrawnMultiple Myeloma | Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.; CelgeneActive, not recruiting
-
Hackensack Meridian HealthTerminatedMultiple MyelomaUnited States
-
TakedaCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States, Canada
-
Millennium Pharmaceuticals, Inc.Completed
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; CelgeneCompleted
-
Hospital Universitari Vall d'Hebron Research InstituteCompleted
-
PfizerActive, not recruitingLymphoma | Diffuse Large B-Cell Lymphoma | Acute Myeloid Leukemia | Multiple MyelomaUnited States
-
Ain Shams UniversityRecruitingPost-Dural Puncture HeadacheEgypt
-
University of MiamiAmgen; Janssen PharmaceuticalsRecruitingMultiple MyelomaUnited States, Sweden
-
Hellenic Society of HematologyGlaxoSmithKlineRecruitingNeoplasms | Multiple Myeloma | Paraproteinemias | Blood Protein Disorders | Corneal Disease | Gammopathy, Monoclonal | Haematologic Disease | Neoplasm, Plasma CellGreece
-
University Hospital, ToulouseRecruiting
-
TakedaActive, not recruiting
-
Dana-Farber Cancer InstituteTakeda; CelgeneActive, not recruitingSmoldering Multiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, France, Korea, Republic of, Canada, Belgium, New Zealand, Russian Federation
-
Emory UniversityMerck Sharp & Dohme LLC; Celgene CorporationCompleted
-
Dana-Farber Cancer InstituteNovartisCompletedMultiple Myeloma in RelapseUnited States
-
University Hospital, ToulouseTakeda; CelgeneTerminated
-
Weill Medical College of Cornell UniversityPfizer; Celgene CorporationTerminatedMultiple MyelomaUnited States